Australia is gain access to innovative treatment for obesity: Retatrutide. This new dual compound – acting on both GLP-1 and GIP receptors – demonstrates remarkable results in global research, indicating substantial drops in body fat. While regulatory clearance hasn't occurred with Australian regulators, many people struggling obesity could vie